Discover the newest research about AI innovations in ๐ Oncology.
Exploring biomarkers in high-risk prostate cancer: 50-75% relapse rate post-treatment. Genomic profiling enhances precision oncology. ๐๐ฌ
New AI tool ShortStop aids in discovering microproteins in the human genome, potentially impacting health and disease research. ๐งฌ๐
AI enhances Optical Coherence Tomography (OCT) for disease detection, improving diagnostic accuracy and patient outcomes. ๐๐ฉบ
AI in Colorectal Cancer: VGG16 Model Achieves 78.44% Accuracy for 5-Year Survival Prediction ๐๐ค
AI models excel in interpreting mammograms, enhancing breast cancer detection rates while maintaining low recall rates. ๐๐ฉบ
๐ Retinoblastoma biomarkers research shows steady growth, with China leading publications. Key hotspots include liquid biopsy and AI integration. ๐ฌ
AI enhances oncology from risk assessment to treatment, improving accuracy and personalization. Key challenges include validation and data security. ๐ค๐๏ธ
Deep learning enhances ccRCC diagnosis with 96.67% accuracy, revealing TME’s role in immunotherapy response. ๐๐งฌ
Fecal microbiota impacts lung cancer immunotherapy response. Key taxa identified: Bacteroides caccae, Prevotella copri. ๐๐ฆ
Integrating mHealth in oncology trials boosts patient engagement and data collection. ๐ฑ๐ Key for equitable access!
